Tag: MERS-CoV
New study spotlights effective strategy against COVID-19 variants: the E7 monoclonal antibody
In a recent study published in the Science Advances Journal, a group of researchers developed potent monoclonal antibodies from a severe acute respiratory syndrome coronavirus (SARS-CoV) survivor vaccinated with BNT162b2 that targets the receptor binding domain (RBD) of human angiotensin-converting enzyme 2 (huACE2)-dependent sarbecovirus. Study: Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated […]
